• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Break (1069); Sticking (1597)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 05/24/2016
Event Type  Injury  
Event Description
This case was initially received via regulatory authority (b)(6) on 31-aug-2017.This spontaneous case was reported by a consumer and describes the occurrence of medical device removal ("essure and the fallopian tubes were removed"), embedded device ("essure was stuck on right side during removal causing a bleeding") and procedural haemorrhage ("essure was stuck on right side during removal causing a bleeding") in a (b)(6) female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.In 2011, the patient had essure inserted.On (b)(6) 2016, the patient underwent medical device removal (seriousness criteria medically significant and intervention required), procedural haemorrhage (seriousness criterion medically significant), device breakage ("fragments were left behind") and complication of device removal ("fragments were left behind").On (b)(6) 2016, the patient experienced medical device removal (seriousness criteria medically significant and intervention required), procedural haemorrhage (seriousness criterion medically significant), device breakage ("fragments were left behind") and complication of device removal ("fragments were left behind").On an unknown date, the patient experienced embedded device (seriousness criterion medically significant), musculoskeletal pain ("pain in neck, joints and back") and fatigue ("fatigue").The patient was treated with surgery.At the time of the report, the medical device removal, embedded device, procedural haemorrhage, device breakage, complication of device removal, musculoskeletal pain and fatigue had not resolved.The reporter provided no causality assessment for complication of device removal, device breakage, embedded device, fatigue, medical device removal, musculoskeletal pain and procedural haemorrhage with essure.The reporter commented: essure could not be completely removed, and fragments remained in situ.Therefore, patient is not yet complaint free.If patient wants to get rid of all complaints, the entire uterus must be removed.The list of device similar incidents contains essure reports received by bayer and older cases received by conceptus coded with the same meddra preferred term.In this particular case a search in the database was performed on 04-sep-2017 for the following meddra preferred terms: medical device removal.The analysis in the global safety database revealed 722 cases.Embedded device.The analysis in the global safety database revealed 369 cases.Bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to these meddra pts.Further company follow-up with the regulatory authority is not possible.Incident.No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6894320
MDR Text Key87383702
Report Number2951250-2017-03983
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 09/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberESS305
Was the Report Sent to FDA? No
Date Manufacturer Received08/31/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age39 YR
-
-